0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Allergy and Immunology

Richard F. Lockey, MD; Samuel C. Bukantz, MD
JAMA. 1986;256(15):2076-2077. doi:10.1001/jama.1986.03380150086020.
Text Size: A A A
Published online

Among the most significant contributions to the treatment of the asthmatic patient is the recognition that a second or delayed response by the allergic asthmatic patient to antigen exposure, termed late phase reaction (LPR), is an inflammatory reaction. The LPR has been observed in the skin, the lung, and the nose.

The neutrophil leukocyte is the dominant cell in these reactions, although mononuclear cells, basophils, and eosinophils participate. There is evidence that soluble factors (histamine-releasing activity from neutrophils) stimulate redegranulation of mast cells that contributes to the induction of bronchial hyperreactivity.1 This inflammatory component is also induced by irritants, such as cold air and ozone, and infectious agents, such as viruses. This has permitted rational interpretation of previously poorly understood clinical and experimental observations. It has stimulated more research and aggressive therapy for both allergic and nonallergic types of asthma with cromolyn (a mast cell—stabilizing agent), oral cromolynlike drugs

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();